Qui sommes-nous? Urgences Traitements Infos médecins Centre de recherche Faire un don Liens
  Rechercher
Home  <  Centre de recherche  <  Publications 2010  <  Publications 2007 Plan d'accèsPlan du siteImprimer www.chuv.ch
Info.onco@chuv.ch
 

2007

1: Appay V, Voelter V, Rufer N, Reynard S, Jandus C, Gasparini D, Lienard D, Speiser DE, Schneider P, Cerottini JC, Romero P, Leyvraz S.
    Combination of transient lymphodepletion with busulfan and fludarabine an peptide vaccination in a phase I clinical trial for patients with advanced melanoma.
J Immunother. 2007 Feb-Mar;30(2):240-50.
2: Appay V., Bosio, A., Lokan, S., Wiencek, Y., Biervert, C., Kusters, D., Devevre, E., Speiser, D.E., Romero, P., Rufer, N., and Leyvraz, S. (2007).
    Sensitive gene expression profiling of human T cell subsets reveals parallel post-thymic differentiation for CD4+ and CD8+ lineages. J Immunol. 179(11):7406-14.
J Immunol. 179(11):7406-14.
3: Barbey, C., Baumgaertner, P., Devevre, E., Rubio-Godoy, V., Derré, L., Bricard, G., Guillaume, P., Luescher, I.F., Liénard, D., Cerottini, J-C., Romero, P., Speiser, D.E., and Rufer, N.
    IL-12 controls cytotoxicity of a novel subset of self antigen-specific human CD28+ cytolytic T cells
J Immunol. 178(6):3566-74.
4: Bieler G., Hasmim M., Monnier Y., Imaizumi N., M. Ameyar, J. Bamat, L. Ponsonnet, S. Chouaib, M. Grell, S. L. Goodman, F. Lejeune and Rüegg C..
    Distinctive role of integrin-mediated adhesion in TNF-induced PKB and NF-kB activation and relevance to endothelial cell survival
Oncogene, 26(39):5722-32
5: Bourgeois H, Vermorken J, Dark G, Jones A, Fumoleau P, Stupp R, Tourani J, Brain E, Nguyen L, Lefresne F, Puozzo C.
    Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours.
Cancer Chemother Pharmacol. 2007 Aug;60(3):407-13. Epub 2007 May 31.
6: Bressoud A, Real del Sarte O., Stiefel S., Mordasini P., Perey L., Bauer J., Leyvraz P.F., Leyvraz S.
    Impact of family structure on long-term survivors of osteosarcoma.
Support Care Cancer (2007) 15: 525-531.
7: Derré L, Bruyninx M, Baumgaertner P, Devevre E, Corthesy P, Touvrey C, Mahnke YD, Pircher H, Voelter V, Romero P, Speiser DE, Rufer N.
    In Vivo Persistence of Codominant Human CD8+ T Cell Clonotypes Is Not Limited by Replicative Senescence or Functional Alteration.
J Immunol. 2007 Aug 15;179(4):2368-79.
8: Fiche M, Lehr HA, Perey L, Delaloye JF, Jeanneret-Sozzi W, Bauer J, Zaman K.
    Breast cancer: pathology, the cornerstone of therapeutic decision
Rev Med Suisse. 2007 ; 18;3:1737-42.
9: Hasmim M., Bieler G. and Rüegg C.
    Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways
J. Thromb Hemost, 5:166-73
10: Hau P, Stupp R, Hegi ME
    MGMT methylation status: the advent of stratified therapy in glioblastoma?
Dis Markers. 2007;23(1-2):97-104. Review.
11: Hermann R., Badoky G., Rushtaller T., Gllimeliuis B. Bajetta E., Schüller J., Saletti P., Bauer J.
    Gemcitabine Plus Capecitabine Compared with Gemcitabine Alone in Advanced Pancreatic Cancer: A randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central, European Cooperative Oncology
Group, J Clin Oncol,. 25 : 2212-2217, June 2007
12: Jorritsma, A., Gomez-Eerland, R., Dokter, M., van de Kasteele, W., Zoet, Y.M., Doxiadis, I.I., Rufer, N., Romero, P., Morgan, R.A., Schumacher, T.N., Haanen, J.B.
    Selecting highly affine and well expressed TCRs for gene therapy of melanoma
Blood. 110(10):3564-72.
13: Ketterer N, Bischof Delaloye A, Helg C, Luthi F, Buchegger F
    Radio-immunothérapie du lymphome folliculaire: Un pas vers la guérison?
Bulletin du Cancer. 2007 ; 94 (9) : 799-806.
14: Mariotti, A.*, Perotti, A., Sessa, C., and Rüegg, C
    “N-cadherin as a therapeutic cancer in Cancer”
Expert Opin. Investig. Drugs 16: 451-465, 2007
15: Mauer M, Stupp R, Taphoorn MJ, Coens C, Osoba D, Marosi C, Wong R, de Witte O, Cairncross JG, Efficace F, Mirimanoff RO, Forsyth P, van den Bent MJ, Weller M, Bottomley A.
    The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study.
Br J Cancer. 2007 Aug 6;97(3):302-7. Epub 2007 Jul 3.
16: Meier R., Gross N., Mühlethaler-Mottet, Flahaut M., Fusco C., Louache F., K. Auderset, Balmas Bourloud K., Ruegg C., G. Vassal, JM. Joseph.
    CXCR4 expression on Neuroblastoma Cells has differential effects on tumor growth and metastasis depending on their intrinsic malignant potential
PLoS One, Oct 10;2(10):e1016.
17: Montemurro M, Kiefer T, Schüler F, Al-Ali HK, Wolf HH, Herbst R, Haas A, Helke K, Theilig A, Lotze C, Hirt C, Niederwieser D, Schwenke M, Krüger WH, Dölken G.
    Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche Studiengruppe Hamato-Onkologie OSHO-53 phase II study.
Ann Oncol. 2007 Apr;18(4):665-71.
18: Moreau P. Attal M., Garban F. Hulin C., Facon T., Marit G., Michallet M., Doyen C., Leyvraz S., Mohty M., Wetterwald M., Mathiot C., Caillot D., Berthoud C., Benboubker L., Garderet L., Chaleteix C., Traulle C., Fuzibet J.G., Jaubert J., Lamy T., Casassus P., Dib M., Kolb B., Dorvaux V., Grosbois B., Yakoub-Agha I., Harousseau J.L., Avet-Loiseau H.
    Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
Leukemia 21 : 2020-2024, 2007
19: Mutter N. and Rüegg C.
    Anti-angiogenic therapies in cancer: achievements and open questions
Bull Cancer. 94(9):753-62
20: Nay C., Luthi F, Ketterer N, Bauer J, Leyvraz S
    Cancers de l’adulte jeune
Rev Med Suisse. 2007 May 23;3(112):1305-6, 1308-10.
21: Paus C, Murat A, Stupp R, Regli L, Hegi M.
    Role of MGMT and clinical applications in brain tumours
Bull Cancer. 2007 Sep 1;94(9):769-73
22: Perey L., R. Paridaens, H. Hawle, Zaman K.*, F. Nolé, H. Wildiers, M. Fiche, D. Dietrich, P. Clément, D. Köberle, A. Goldhirsch, and B. Thürlimann
    Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)
Ann Oncol. 2007 Jan;18(1):64-9
23: Rollini P., Faes-van’t Hull, S. Kaiser, U. Kapp, S. Leyvraz
    Phenotypic and functional analysis of human fetal liver hematopoietic stem cells in culture
.Stem Cells Dev.16 : 281-296, 2007.
24: Romero P., Zippelius, A., Kurth, I., Pittet, M.J., Touvrey, C., Iancu, E.M., Corthesy, P., Devevre, E., Speiser, D.E., and Rufer N.
    Four functionally distinct populations of human effector-memory CD8+ T lymphocytes
J Immunol. 178(7): 4112-19.
25: Rossel M, Burnier M, Stupp R.
    Informed consent: true information or institutional review board-approved disinformation?
J Clin Oncol. 2007 Dec 20;25(36):5835-6.
26: Rosselet Anne, Ketterer N.
    Myélome multiple.
27: Rossier-Pansier L., Baruthio F., Rüegg C., and Mariotti A.
    “Compartmentalization in membrane rafts defines a pool of N-cadherin associated with catenins and not engaged in cell-cell junctions in melanoma cells”
J. Cell. Biochem, 103: 957-971, 2008
28: Roth AD, Fazio N, Stupp R, Falk S, Bernhard J, Saletti P, Köberle D, Borner MM, Rufibach K, Maibach R, Wernli M, Leslie M, Glynne-Jones R, Widmer L, Seymour M, de Braud F
    Swiss Group for Clinical Cancer Research. Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research
J Clin Oncol. 2007 Aug 1;25(22):3217-23
29: Sappino A.P., Leyvraz S.
    Regional hospital, clinic, and physician collaboration in oncology care
Rev. Med. Suisse 23, 1283-1284, 2007.
30: Stupp R, Hegi ME, Gilbert MR, Chakravarti A.
    Chemoradiotherapy in malignant glioma: standard of care and future directions.
J Clin Oncol. 2007 Sep 10;25(26):4127-36.
31: Stupp R, Hegi ME.
    Methylguanine methyltransferase testing in glioblastoma: when and how?
J Clin Oncol. 2007 Apr 20;25(12):1459-60
32: Stupp R., Hegi ME
    Neuro-oncology: oligodendroglioma and molecular markers.
Lancet Neurol. 2007 Jan;6(1):10-2.
33: Stupp R., Hegi ME
    Targeting brain-tumor stem cells. Nat Biotechnol
Nat Biotechnol. 2007 Feb;25(2):193-4.
34: Stupp R., Pica A, Mirimanoff RO, Michielin O.
    A practical guide for the management of gliomas
Bull Cancer. 2007 Sep 1;94(9):817-22
35: Stupp R., Reni M, Gatta G, Mazza E, Vecht C.
    Anaplastic astrocytoma in adults
Crit Rev Oncol Hematol. 2007 Jul;63(1):72-80.
36: Stupp R., Ruegg C.
    Integrin inhibitors reaching the clinic
. J Clin Oncol. 2007 May 1;25(13):1637-8.
37: Thadikkaran, L., Menzel, O., Tissot, J-D., and Rufer, N.
    Proteomic and transcriptomic analysis of human CD8+ T lymphocytes over-expressing telomerase.
Proteomics Clin Appl. 1:299-311.
38: Trojan A, Rajeswaran R, Montemurro M, Mütsch M, Steffen R.
    Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.
J Clin Virol. 2007 Sep;40(1):80-3. Epub 2007 Jul 20
39: Wavre A., S. Baur A., Betz M., Dominique Muhlematter, Zaman K. and Ketterer N.
    Intracerebral plasmacytoma as an initial presentation of multiple myeloma
Neuro-Oncology 2007; 9(3):370-2
40: Weder W, Stahel RA, Bernhard J, Bodis S, Vogt P, Ballabeni P, Lardinois D, Betticher D, Schmid R, Stupp R, Ris HB, Jermann M, Mingrone W, Roth AD, Spiliopoulos A
    Swiss Group for Clinical Cancer Research. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
Ann Oncol. 2007 Jul;18(7):1196-202. Epub 2007 Apr 11
41: Zaman K., Alexandra Ambrosetti, Lucien Perey, Wendy Jeanneret-Sozzi, Jean-François Delaloye, Dominique De Ziegler.
    Cancer du sein chez la jeune femme: Traitements adjuvants et désir de grossesse
Rev Med Suisse 2007; 3:1298-304
42: Zaman K., Favet L., Schusterbauer C. et Pierre-Yves Dietrich
    Les bisphosphonates en oncologie : incertitudes et controverses en 2007.
Rev Med Suisse 2007; 3:1317-21


Retour en haut de la page
Dernière modification le 20.05.2010